Menu
CircRNA (Circular RNA) is a stable type of non-coding RNA with a covalently closed circular structure, making it resistant to degradation. It can regulate gene expression through the “miRNA sponge” mechanism and plays a key role in various diseases. Due to its high stability and disease specificity, CircRNA is emerging as an ideal biomarker and a research hotspot in the biomedical field.
Leveraging client-provided gene or amino acid sequences, Yaohai Bio-Pharma delivers end-to-end CircRNA solutions.
Yaohai Bio-Pharma delivers tailored solutions for global clients, meeting diverse project requirements with excellence and efficiency.
Proven track record of over 100 successful projects, spanning preclinical studies and Phase I/II/III clinical trials, including US–China dual submissions and Australian regulatory filings.
A robust GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines across the entire product lifecycle.
Powered by industry-leading scientists and cross-functional experts, our team delivers CRDMO projects with speed, precision, and deep technical insight.
